Studies
Pick a study to open its workspace. Modules (Mock Shells, Data Hub, Files, Tracker, and the rest) run inside the selected study.
ONC-204-301
Metastatic NSCLC
Protocol v4.1 · SAP v2.0 · 428 subjects
Open workspace →
ONC-118-402
HER2+ breast cancer
Protocol v2.0 · SAP draft · 186 subjects
Open workspace →
VAC-302-011
RSV vaccine — adults ≥60
Protocol v1.1 · libraries provisioning
Open workspace →
HEM-220-015
Relapsed / refractory AML
CSR delivered · read-only archive
Open workspace →
All studies
4 studies · tenant X Pharma + partners| Protocol | Study name | Deliverable Type | Lead Programmer | Statistician | FPFV | LPLV | DB lock | Phase | Status |
|---|---|---|---|---|---|---|---|---|---|
| ONC-204-301 |
Metastatic NSCLC
Submission · NSCLC 2L+
|
Submission | Jordan Patel | Riley Nguyen | 2023-04-12 | 2025-11-30 | 2026-03-15 | 3 | Active |
| ONC-118-402 |
HER2+ breast cancer
DMC · HER2+ mBC
|
DMC | Alex Rivera | Dana Brooks | 2024-01-08 | — | — | 2 | Active |
| VAC-302-011 |
RSV vaccine — adults ≥60
Interim analysis · RSV prevention
|
Interim analysis | Sam Okonkwo | Taylor Kim | 2025-09-01 | — | — | 3 | Startup |
| HEM-220-015 |
Relapsed / refractory AML
Regulatory · R/R AML
|
Regulatory | Chris Nguyen | Priya Shah | 2021-06-20 | 2024-02-14 | 2024-05-01 | 1/2 | Closed |